News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER launches second phase of adult observational study
Throughout this phase, RECOVER will continue to collect information from about 5,000 people for 2 years to build a deeper understanding of how Long COVID affects people over time.
Feature
169 Results
169 Results
RECOVER hub brings Long COVID research to rural, low-income communities
ISCORE, a RECOVER hub spanning 10 states and Puerto Rico, is bringing Long COVID studies to communities often underfunded in research, drawing on decades of HIV experience to tackle another new infectious disease.
Feature
RECOVER Research Update: June 2026
RECOVER scientists, study participants, and Representatives are working together to make new discoveries about Long COVID and how to diagnose, prevent, and treat its symptoms.
Feature
RECOVER builds on current knowledge about symptoms affecting the lungs and heart
As RECOVER’s adult observational study moves to the next phase, researchers continue to explore the various causes of common Long COVID symptoms, such as difficulty breathing.
Feature
Representatives identify community needs to improve support for people with Long COVID
The co-chairs of RECOVER’s National Community Engagement Group conducted listening sessions with 24 Community Representatives and detailed key themes in a new report.
Feature
Participant advisory group at RECOVER hub raises awareness about Long COVID
The ILLInet PARATROOPers, a a group of RECOVER study participants, collaborate with researchers to center the voices of Long COVID patients, improve RECOVER studies, and raise awareness about the condition.
Feature
R3 Seminar Recap: Impact of Long COVID on neurocognitive function
At the RECOVER Research Review (R3) Seminar held on April 14, RECOVER researchers presented findings on how Long COVID affects the brain, including difficulties with thinking clearly, memory, and concentration. They also outlined future research opportunities to better understand neurocognitive symptoms and how other body systems impact brain health.
R3 Seminar Recap
RECOVER-TLC announces public comment period for upcoming clinical trial
Patients, caregivers, and researchers will have 2 weeks to provide input on plans to test whether glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can help improve Long COVID symptoms.
Announcement
RECOVER continues to focus on understanding symptoms that affect the brain
RECOVER researchers are continuing plans to explore cognitive symptoms like brain fog in the initiative’s adult observational study, one of the most common but least understood symptoms of Long COVID.
Feature